Literature DB >> 25082757

Understanding counselors' implementation of tobacco cessation services with patients.

Lillian T Eby1, Tanja C Laschober2, Jessica L Muilenburg3.   

Abstract

This study aimed to understand substance use disorder counselors' implementation of evidence-based tobacco cessation services (TCS) with their patients who smoke. Drawing from an established adoption of innovations framework, we investigated the association between counselors' perceptions of the availability of TCS (both pharmacotherapies and behavioral treatments) in their treatment program and the implementation of TCS (both pharmacotherapies and behavioral treatments) with their patients who smoke and whether this association is moderated by the strength of an organization's climate for implementation and the fit of the innovation with users' values. Data were collected in 2010 from 682 counselors working in 239 treatment programs across the U.S. that offer evidence-based TCS. Mixed-effect models showed that perceived availability of TCS was related with greater TCS implementation. This relationship was moderated by several indicators of climate for implementation but not by the fit of the innovation with users' values.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Addiction treatment; Adoption research; Evidence-based practices; Implementation research; Smoking cessation

Mesh:

Year:  2014        PMID: 25082757      PMCID: PMC4175141          DOI: 10.1016/j.jsat.2014.06.007

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  35 in total

1.  Staff beliefs about addiction treatment.

Authors:  R F Forman; G Bovasso; G Woody
Journal:  J Subst Abuse Treat       Date:  2001-07

2.  Implementing computerized technology: an organizational analysis.

Authors:  K J Klein; A B Conn; J S Sorra
Journal:  J Appl Psychol       Date:  2001-10

3.  Can the national addiction treatment infrastructure support the public's demand for quality care?

Authors:  A Thomas McLellan; Deni Carise; Herbert D Kleber
Journal:  J Subst Abuse Treat       Date:  2003-09

4.  Characteristics, beliefs, and practices of community clinicians trained to provide manual-guided therapy for substance abusers.

Authors:  Samuel Ball; Ken Bachrach; Jacqueline DeCarlo; Chris Farentinos; Melodie Keen; Terence McSherry; Douglas Polcin; Ned Snead; Richard Sockriter; Paulen Wrigley; Lucy Zammarelli; Kathleen Carroll
Journal:  J Subst Abuse Treat       Date:  2002-12

5.  A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery.

Authors:  Judith J Prochaska; Kevin Delucchi; Sharon M Hall
Journal:  J Consult Clin Psychol       Date:  2004-12

6.  What are the correlates of substance abuse treatment counselor salaries?

Authors:  Todd A Olmstead; J Aaron Johnson; Paul M Roman; Jody L Sindelar
Journal:  J Subst Abuse Treat       Date:  2005-10

7.  Smoking cessation interventions in Australian drug treatment agencies: a national survey of attitudes and practices.

Authors:  Raoul A Walsh; Jennifer A Bowman; Flora Tzelepis; Christophe Lecathelinais
Journal:  Drug Alcohol Rev       Date:  2005-05

8.  Climate for innovation, 12-step orientation, and tobacco cessation treatment.

Authors:  Jessica L Muilenburg; Tanja C Laschober; Lillian T Eby
Journal:  J Subst Abuse Treat       Date:  2013-11-12

9.  Mental health provider attitudes toward adoption of evidence-based practice: the Evidence-Based Practice Attitude Scale (EBPAS).

Authors:  Gregory A Aarons
Journal:  Ment Health Serv Res       Date:  2004-06

10.  Counselor and clinical supervisor perceptions of OASAS tobacco-free regulation implementation extensiveness, perceived accountability, and use of resources.

Authors:  Tanja C Laschober; Lillian T Eby
Journal:  J Psychoactive Drugs       Date:  2013 Nov-Dec
View more
  7 in total

1.  Factors Linked to Substance Use Disorder Counselors' (Non)Implementation Likelihood of Tobacco Cessation 5 A's, Counseling, and Pharmacotherapy.

Authors:  Tanja C Laschober; Jessica L Muilenburg; Lillian T Eby
Journal:  J Addict Behav Ther Rehabil       Date:  2015

2.  Factors associated with implementation of the 5A's smoking cessation model.

Authors:  C Martínez; Y Castellano; A Andrés; M Fu; L Antón; M Ballbè; P Fernández; S Cabrera; A Riccobene; E Gavilan; A Feliu; A Baena; M Margalef; E Fernández
Journal:  Tob Induc Dis       Date:  2017-11-02       Impact factor: 2.600

3.  Occupational health professionals' attitudes, knowledge, and motivation concerning smoking cessation-Cross-sectional survey.

Authors:  Maarit Malin; Nina Jaakkola; Ritva Luukkonen; Antero Heloma; Anne Lamminpää; Kari Reijula
Journal:  J Occup Health       Date:  2020-01       Impact factor: 2.708

4.  Associations Between Organizational Culture, Workplace Health Climate, and Employee Smoking at Smaller Workplaces.

Authors:  Christine M Kava; Edith A Parker; Barbara Baquero; Susan J Curry; Paul A Gilbert; Michael Sauder; Daniel K Sewell
Journal:  Tob Use Insights       Date:  2019-03-15

5.  Organizational Factors Moderating Changes in Tobacco Use Dependence Care Delivery Following a Comprehensive Tobacco-Free Workplace Intervention in Non-Profit Substance Use Treatment Centers.

Authors:  Kathy Le; Tzuan A Chen; Isabel Martinez Leal; Virmarie Correa-Fernández; Ezemenari M Obasi; Bryce Kyburz; Teresa Williams; Kathleen Casey; Matthew Taing; Daniel P O'Connor; Lorraine R Reitzel
Journal:  Int J Environ Res Public Health       Date:  2021-10-06       Impact factor: 3.390

6.  Organizational culture and the adoption of anti-smoking initiatives at small to very small workplaces: An organizational level analysis.

Authors:  Christine M Kava; Edith A Parker; Barbara Baquero; Susan J Curry; Paul A Gilbert; Michael Sauder; Daniel K Sewell
Journal:  Tob Prev Cessat       Date:  2018-12-19

7.  A qualitative assessment of the smoking policies and cessation activities at smaller workplaces.

Authors:  Christine M Kava; Edith A Parker; Barbara Baquero; Susan J Curry; Paul A Gilbert; Michael Sauder; Daniel K Sewell
Journal:  BMC Public Health       Date:  2018-09-05       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.